INNATE PHARMA: ifrs:AdjustmentsForDecreaseIncreaseInTradeAndOtherReceivables
| Value | {"amount": -4204000.0} |
|---|---|
| Period | 2022-01-01 – 2022-12-31 |
| Status | current |
| Entity | INNATE PHARMA |
Provenance
Source: ESEF — Europäische Jahresabschlüsse (iXBRL) (Public filings (ESEF-Verordnung))
Reference:
Retrieved: 2026-08-24T00:10:15.202100+02:00
Raw response sha256:
Cite as: FACTANKER, https://factanker.com/fact/7623e56d-4a7f-4439-a8e7-cb9c19b610e6
Source: ESEF — Europäische Jahresabschlüsse (iXBRL) (Public filings (ESEF-Verordnung))
Reference:
esef:9695002Y8420ZB8HJE29:2023-12-31Retrieved: 2026-08-24T00:10:15.202100+02:00
Raw response sha256:
8cc6e40d8d62bf3f280603498c300fb9…Cite as: FACTANKER, https://factanker.com/fact/7623e56d-4a7f-4439-a8e7-cb9c19b610e6
History
- no predecessors — first report